Sai Life Sciences Limited (NSE:SAILIFE)

Market Cap	159.40B
Revenue (ttm)	16.95B
Net Income (ttm)	1.70B
Shares Out	208.52M
EPS (ttm)	8.61
PE Ratio	88.79
Forward PE	67.36
Dividend	n/a
Ex-Dividend Date	n/a

Volume	365,287
Average Volume	596,098
Open	753.00
Previous Close	748.90
Day's Range	744.10 - 768.50
52-Week Range	636.10 - 808.80
Beta	n/a
RSI	55.27
Earnings Date	Jul 16, 2025

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company offers medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 2,845
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SAILIFE

Financial Performance

In 2024, Sai Life Sciences's revenue was 16.95 billion, an increase of 15.66% compared to the previous year's 14.65 billion. Earnings were 1.70 billion, an increase of 105.45%.